Gemzar 200 Mg Injection

Product Description

Gemzar 200 Mg Injection is a nucleoside analog used as chemotherapy. It is marketed as Gemzar by Eli Lilly and Company. This medication is indicated for the treatment in various carcinomas: non-small cell lung cancer, pancreatic cancer, bladder cancer and breast cancer.

Detailed Description:

• As with fluorouracil and other analogues of pyrimidines, the drug replaces one of the building blocks of nucleic acids, in this case cytidine, during DNA replication

• The process arrests tumour growth, as new nucleosides cannot be attached to the "faulty" nucleoside, resulting in apoptosis (cellular "suicide")

• It is being investigated for use in esophageal cancer, and is used experimentally in lymphomas and various other tumour types

Other Information

• Port of Dispatch: Mumbai
• Production Capacity: 3000-4000
• Delivery Time: 7-8 days